Literature DB >> 12533032

Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.

Muhammad Wasif Saif1, Jon L Hopkins, Steven D Gore.   

Abstract

Autoimmune paraneoplastic syndromes are commonly encountered in patients with myelodysplastic syndromes (MDS). A review of case reports and small series suggest as many as 10% of MDS patients may experience various autoimmune syndromes. Clinical manifestations of such phenomena may include an acute systemic vasculitic syndrome, skin vasculitis, fever, arthritis, pulmonary infiltrates, peripheral polyneuropathy, inflammatory bowel disease, glomerulonephritis, and even classical connective tissue disorders, such as relapsing polychondritis. On the other hand, asymptomatic immunologic abnormalities have also been reported in these patients. These autoimmune manifestations frequently respond to immunosuppressive agents including steroids and occasional hematologic responses to steroid therapy have also been reported. We report five patients with history of MDS who manifested different spectrums of autoimmune phenomena including: pyoderma gangrenosum (PG), vasculitis, Coombs negative hemolytic anemia, idiopathic thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy (CIDP). We also review the incidence, nature, course and response to therapy of these manifestations and discuss potential pathogenic mechanisms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12533032     DOI: 10.1080/1042819021000016186

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  24 in total

Review 1.  Concurrent FSGS and Hodgkin's lymphoma: case report and literature review on the link between nephrotic glomerulopathies and hematological malignancies.

Authors:  Abdalla Mallouk; Phuong-Thu T Pham; Phuong-Chi T Pham
Journal:  Clin Exp Nephrol       Date:  2006-12-20       Impact factor: 2.801

2.  Myelodysplastic syndrome.

Authors:  Shinji Nakao; H Joachim Deeg; Takayuki Ishikawa; Judith Marsh; Alan List; Masao Tomonaga
Journal:  Int J Hematol       Date:  2005-12       Impact factor: 2.490

Review 3.  Myeloid disorders after autoimmune disease.

Authors:  Prajwal C Boddu; Amer M Zeidan
Journal:  Best Pract Res Clin Haematol       Date:  2019-02-07       Impact factor: 3.020

4.  Immunologic abnormalities in myelodysplastic syndromes: clinical features and characteristics of the lymphoid population.

Authors:  Dragomir Marisavljević; Nada Kraguljac; Zoran Rolović
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

5.  Antibody binding to megakaryocytes in vivo in patients with immune thrombocytopenia.

Authors:  Donald M Arnold; Ishac Nazi; Lisa J Toltl; Catherine Ross; Nikola Ivetic; James W Smith; Yang Liu; John G Kelton
Journal:  Eur J Haematol       Date:  2015-03-13       Impact factor: 2.997

6.  The transcriptome of CMML monocytes is highly inflammatory and reflects leukemia-specific and age-related alterations.

Authors:  Anca Franzini; Anthony D Pomicter; Dongqing Yan; Jamshid S Khorashad; Srinivas K Tantravahi; Hein Than; Jonathan M Ahmann; Thomas O'Hare; Michael W Deininger
Journal:  Blood Adv       Date:  2019-10-22

7.  Myelodysplastic syndrome: An update on diagnosis and therapy.

Authors:  Ahrin Koppel; Gary Schiller
Journal:  Curr Hematol Malig Rep       Date:  2009-01       Impact factor: 3.952

Review 8.  The thrombocytopenia of WAS: a familial form of ITP?

Authors:  Ted S Strom
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

Review 9.  Myelodysplastic syndrome: an update on diagnosis and therapy.

Authors:  Ahrin Koppel; Gary Schiller
Journal:  Curr Oncol Rep       Date:  2008-09       Impact factor: 5.075

10.  Non-specific interstitial pneumonia as the initial presentation of biphenotypic acute leukemia: a case report.

Authors:  Arun V Mohan; Venktesh R Ramnath; Eva Patalas; Eyal C Attar
Journal:  Cases J       Date:  2009-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.